comparemela.com

Latest Breaking News On - Branded pharmaceuticals - Page 8 : comparemela.com

Endo International plc (NASDAQ:ENDP) Expected to Announce Quarterly Sales of $631.37 Million

Wall Street brokerages predict that Endo International plc (NASDAQ:ENDP – Get Rating) (TSE:ENL) will announce $631.37 million in sales for the current quarter, Zacks reports. Three analysts have provided estimates for Endo International’s earnings. The highest sales estimate is $635.40 million and the lowest is $626.42 million. Endo International reported sales of $717.92 million during […]

United-states
Piper-sandler
Russell-investments-group-ltd
Sterling-investment-advisors-ltd
Carolina-wealth-advisors
Zacks-investment-research
Nasdaq
Endo-international
Its-branded-pharmaceuticals
Endo-international-company-profile-get-rating
Barclays
Citigroup

Endo International (NASDAQ:ENDP) Shares Gap Up to $2.43

Endo International plc (NASDAQ:ENDP – Get Rating) (TSE:ENL) gapped up prior to trading on Wednesday . The stock had previously closed at $2.43, but opened at $2.54. Endo International shares last traded at $2.52, with a volume of 58,925 shares changing hands. Several equities analysts recently weighed in on the stock. Citigroup cut their price […]

United-states
Thomson-reuter
Yousif-capital-management
Geode-capital-management
Zacks-investment-research
Parametric-portfolio-associates
Nasdaq
Endo-international
Jackson-creek-investment-advisors
Its-branded-pharmaceuticals
Barclays
Citigroup

Dermapharm Holding SE: Continuous growth of Group revenues and adjusted Group EBITDA in 2022

DGAP-News: Dermapharm Holding SE / Key word: Forecast Dermapharm Holding SE: Continuous growth of Group revenues and adjusted Group EBITDA in 2022 29.03.2022 / 07:30 The issuer. | March 29, 2022

Brehna
Sachsen-anhalt
Germany
Austria
United-states
Munich
Bayern
Spain
Ukraine
Spanish
German
Britta-hamberger

Cosmos Holdings, Inc.: Cosmos Holdings CEO Provides Letter to Shareholders

CHICAGO, IL / ACCESSWIRE / March 23, 2022 / Cosmos Holdings, Inc. ("the Company") (Nasdaq:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded

United-states
Germany
Athens
Attikír
Greece
United-kingdom
Singapore
Brazil
Chios
Perifereia-voreiou-aigaiou
China
Italy

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.